Trulicity ® (dulaglutide)

This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. Please refer to the link for full prescribing information: Trulicity Summary of Product Characteristics (SmPC)

Trulicity® (dulaglutide): Air bubbles in the dulaglutide pen

Air bubbles in the dulaglutide pen are normal. They will not cause harm or affect the dose.

Background information

Dulaglutide is to be injected subcutaneously under the skin into the fat tissue layer (subcutaneous injection).1

Small air bubbles are not a problem in this type of injection.2

Injecting air bubbles is more of a safety concern when medicines need to be injected into a vein (intravenous administration).2

References

1. Trulicity [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.

2. Data on file, Eli Lilly and Company and/or one of its subsidiaries.

Date of Last Review: December 06, 2019

Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com

Available Mon - Fri, 8am - 4pm, excluding Bank Holidays

Or you can

Ask us a question Chat with Us If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a question